Acasă › Cancer pulmonar cu celule non-pătrate › Ohio › Akron
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Akron, OH
22 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Akron (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Cleveland Clinic Akron General, Akron
- Aultman Health Foundation, Canton · La 21 mi distanță
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
În curs de recrutareFaza 3
- Aultman Health Foundation, Canton · La 21 mi distanță
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
În curs de recrutareFaza 3
- Akron General Medical Center, Akron
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Aultman North, North Canton · La 15 mi distanță
- Aultman Massillon, Massillon · La 20 mi distanță
- Aultman Orrville Hospital, Orrville · La 21 mi distanță
- și încă 2
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Research Site, Canton · La 21 mi distanță
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Aultman Hospital, Canton · La 21 mi distanță
Pan-tumor MRD Study
În curs de recrutareStudiu observațional
- Gabrail Cancer Center, Canton · La 21 mi distanță
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
În curs de recrutareFaza 2/3
- Gabrail Cancer Center Research, Canton · La 21 mi distanță
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
În curs de recrutareFaza 2
- Gabrail Cancer Center, Canton · La 21 mi distanță
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
În curs de recrutareFaza 2/3
- Tricounty Hematology and Oncology - Massillon, Massillon · La 20 mi distanță
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
În curs de recrutareFaza 1/2
- Gabrail Cancer Center Research, Canton · La 21 mi distanță
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Gabrail Cancer Center, Canton · La 21 mi distanță
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
În curs de recrutareFaza 2
- Gabrail Cancer and Research Center, Canton · La 21 mi distanță
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Cleveland Clinic Mercy Hospital, Canton · La 21 mi distanță
- Aultman Health Foundation, Canton · La 21 mi distanță
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Aultman Health Foundation, Canton · La 21 mi distanță
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Aultman Health Foundation, Canton · La 21 mi distanță
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- Aultman Health Foundation, Canton · La 21 mi distanță
GEMINI-NSCLC: NSCLC Biomarker Study
În curs de recrutareStudiu observațional
- Aultman Hospital, Canton · La 21 mi distanță
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
În curs de recrutareFaza 1
- Gabrail Cancer & Research Center, Canton · La 21 mi distanță
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Research Site 138, Canton · La 21 mi distanță
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
În curs de recrutareFaza 1/2
- Gabrail Cancer Center Research, Canton · La 21 mi distanță
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
În curs de recrutareFaza 1/2
- Gabrail Cancer Research Center, Canton · La 21 mi distanță
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY120 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH56 studii
- Washington, DC55 studii
Alte studii în Akron
- Cancer pulmonar16 studii
- Cancer (toate tipurile)13 studii
- Cancer de sân13 studii
- Cancer de prostată9 studii
- Leucemie mieloasă acută8 studii
- Melanom8 studii
- Cancer pulmonar cu celule mici8 studii
- Cancer metastatic8 studii
- Cancer colorectal8 studii
- Boală hepatică steatoasă7 studii
- Cancer endometrial6 studii
- Cancer ovarian6 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.